Skip to content

Anti-Mycoplasma pneumoniae Antibody, Serum (IgG and IgA) - Qualitative/Quantitative

Published: August 9, 2026Updated: August 16, 2026

This test measures the presence of antibodies in your blood against *Mycoplasma pneumoniae*, a common bacterial cause of respiratory infections like pneumonia and bronchitis.

Quick summary

["Helps diagnose infections caused by *Mycoplasma pneumoniae* by detecting immune system response."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
23240-5
Short code
M bovis Ab Ser Ql IA
Synonyms
M bovis Ab Ser Ql IA
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
ia
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

This test measures specific substances in your body that can show how well certain organs are working or whether an infection or other condition may be present. Your doctor uses these measurements, along with your symptoms and medical history, to get a clearer picture of your overall health.

The test detects two types of antibodies—IgG and IgA—produced by your immune system in response to infection. IgG antibodies typically appear weeks after exposure and persist longer, while IgA antibodies may appear earlier but are less durable. This helps differentiate between past infection, current infection, or exposure.

Your doctor may order this test if you have symptoms that need a closer look, if a routine checkup calls for it, or if you are being monitored for an ongoing condition. It can also help confirm or rule out a diagnosis, guide treatment decisions, or show how well a treatment is working over time.

Your healthcare provider may recommend this test if you have symptoms like persistent cough, fever, or chest pain that suggest *Mycoplasma pneumoniae* infection, especially if other tests (like a chest X-ray or culture) are inconclusive. It’s also used in cases of atypical pneumonia that doesn’t respond to typical antibiotics.

The test is usually done in a lab, clinic, or your doctor's office. Depending on the type of test, a small sample such as blood, urine, or a swab may be collected, and the process often takes only a few minutes. Most people can go home right afterward and return to their normal daily activities.

A blood sample is drawn from a vein in your arm. The sample is then analyzed using an immunoassay method to measure antibody levels. Results are reported as either qualitative (positive/negative) or quantitative (specific concentration levels).

Results are generally reported as normal or abnormal. A normal result usually means your values fall within the expected range, while an abnormal result means something stood out and may need follow-up. Many factors can affect results, so your doctor will explain exactly what yours mean for your situation.

A positive result indicates the presence of antibodies, suggesting past or current infection. A negative result means no detectable antibodies, which may mean no infection or insufficient time since exposure. False negatives can occur if tested too early after infection.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance: Role in Diagnosis and Management

Short name

Mycoplasma pneumoniae antibody test

Frequently asked questions

This test is particularly useful for diagnosing *Mycoplasma pneumoniae* infections in patients with atypical symptoms, where other tests like a throat culture may not be conclusive. Early detection can guide antibiotic treatment choices, though some infections may resolve without antibiotics. Chronic or recurrent infections may also warrant further investigation.
A positive result usually means the test detected the substance or condition it was designed to find. It does not always mean you are seriously ill, and follow-up testing is sometimes needed to confirm the finding. Your doctor will review the result with you and explain what the next steps should be.
A positive result means your immune system has detected antibodies against *Mycoplasma pneumoniae*, which could indicate you’ve had an infection in the past or are currently infected. However, this doesn’t always mean you’re actively sick—some people may have lingering antibodies without symptoms. Always discuss results with your doctor.
Yes, in many cases you can have this test even if you feel well. Doctors often use it for screening, routine checkups, or to establish a baseline before symptoms appear. If you have certain risk factors or health concerns, ask your doctor whether this test makes sense for you.
Yes, your doctor may order this test for screening, monitoring, or research purposes even if you don’t have symptoms. Antibodies can persist for months or years after infection, so a negative result doesn’t always mean you’re free of past exposure. Follow-up testing may be needed.
Results are typically available within 1–3 business days, depending on lab processing times. If you need urgent results, your doctor may request expedited testing. Follow-up instructions will be provided by your healthcare team.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy